Why we like health-care stocks in 2024 despite their spotty record in presidential election years


This picture shows an unit dedicated to the production of insulin pens at the factory of the US pharmaceutical company Eli Lilly in Fegersheim, eastern France.

Frederick Florin | AFP | Getty Images

As the old Wall Street adage goes, health care tends to underperform the stock market in presidential election years — and in recent cycles, that’s been true. But, there’s reason to believe this year that many health-related stocks, led by Eli Lilly, could defy historical convention.

This article was originally published on CNBC